Kalaris Therapeutics, Inc. (KLRS): 4 filed Mar 20, 2026

Form type

4

Filing date

Mar 20, 2026

Accession number

0001193125-26-117616

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)